GRO Biosciences Inc. presented successful proof of concept results in two pre-clinical programs representing potential breakthroughs in autoimmune disease and immunogenicity at this week’s Discovery On Target conference.
GRO Biosciences Inc. presented successful proof of concept results in two pre-clinical programs representing potential breakthroughs in autoimmune disease and immunogenicity at this week’s Discovery On Target conference.